Indonesian Citizen, born in Jakarta in 1964, domiciled in Jakarta, Indonesia. Director of the Company since 2017 based on the resolution of the Annual General Meeting of Shareholders (AGMS) dated June 5, 2017 and has been reappointed as Director based on AGMS on May 18, 2020.
He received his Bachelor degree in Accounting Economics from Padjadjaran University in January 1988 in Bandung, and then attended the Master Program of Business Administration from GS Fame Institute of Business in Jakarta in 1995. He started his career in 1988 in several Companies in Internal Audit, Accounting and Budgeting at Gunung Sewu Group of Companies, Mitracorp Pacific Nusantara, and Artha Holdings. He joined PT Kalbe Farma Tbk, as Investor Relation Manager in June 1997, as Assistant Director of Accounting, Finance and Investor Relation from September 2000 to December 2006. He then served as the Finance Director of PT Kalbe Morinaga Indonesia from February 2005 to July 2016 and Director Finance of PT Enseval Putera Megatrading Tbk from May 2007 to June 2008. Later, he served as Director of Kalbe Group’s Finance, Accounting and Tax Division since January 2009. Currently he also serves as the President Commissioner PT Kalgen DNA, Commissioner PT Bifarma Adiluhung, Commissioner PT Emos Global Digital, President Commissioner PT Kalbio Global Medika, Commissioner PT Kalbe Milko Indonesia, President Director PT Saka Farma Laboratories, Director PT Kalbe Genexine Biologics, and Director PT Kalbe Biotek Indonesia.